CAH - Cardinal Health - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US14149Y1082

Pharmaceuticals, Medical Devices, Surgical Supplies, Gloves, Laboratory Products

Cardinal Health Inc. is a leading healthcare services and products company that operates globally, with a presence in the United States, Canada, Europe, Asia, and other international markets. The company provides tailored solutions to a diverse range of healthcare providers, including hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

The company's operations are divided into two main segments: Pharmaceutical and Medical. The Pharmaceutical segment is responsible for distributing a wide range of products, including branded and generic pharmaceuticals, specialty pharmaceuticals, and over-the-counter healthcare and consumer products. This segment also provides specialized services to pharmaceutical manufacturers and healthcare providers, such as operating nuclear pharmacies and radiopharmaceutical manufacturing facilities, repackaging generic pharmaceuticals and over-the-counter healthcare products, and offering pharmacy management services to hospitals.

The Medical segment, on the other hand, focuses on the manufacturing, sourcing, and distribution of Cardinal Health branded medical, surgical, and laboratory products and devices. These products include exam and surgical gloves, needles, syringe, and sharps disposals, compressions, incontinence products, nutritional delivery products, wound care products, single-use surgical drapes, gowns, and apparels, fluid suction and collection systems, urology products, operating room supply products, and electrode product lines. Additionally, this segment distributes a range of national brand products, including medical, surgical, and laboratory products, and provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers. The segment also assembles and sells sterile and non-sterile procedure kits.

With a rich history dating back to 1979, Cardinal Health Inc. is headquartered in Dublin, Ohio, and has established itself as a trusted partner to healthcare providers around the world. The company's commitment to providing high-quality products and services has enabled it to build a strong reputation in the healthcare industry.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for CAH - Cardinal Health  - Stock Price & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for CAH - Cardinal Health  - Stock Price & Dividends

CAH Stock Overview

Market Cap in USD 23,212m
Sector Healthcare
Industry Medical Distribution
GiC SubIndustry Health Care Distributors
TER 0.00%
IPO / Inception 1987-12-31

CAH Stock Ratings

Growth 5y 82.7
Fundamental 49.7
Dividend 54.8
Rel. Performance vs Sector -1.63
Analysts 3.47/5
Fair Price Momentum 103.07 USD
Fair Price DCF 217.34 USD

CAH Dividends

Dividend Yield 12m 2.04%
Yield on Cost 5y 5.13%
Dividends CAGR 5y 0.80%
Payout Consistency 95.5%

CAH Growth Ratios

Growth 12m 9.47%
Growth Correlation 12m 28%
Growth Correlation 3m -26%
CAGR 5y 20.20%
CAGR/Mean DD 5y 2.48
Sharpe Ratio 12m 0.19
Alpha vs SP500 12m -8.67
Beta vs SP500 5y weekly 0.83
ValueRay RSI 65.30
Volatility GJR Garch 1y 19.83%
Price / SMA 50 0.7%
Price / SMA 200 -3.4%
Current Volume 1383.5k
Average Volume 20d 1864.4k

External Links for CAH Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
XStocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of CAH stocks?
As of July 27, 2024, the stock is trading at USD 98.35 with a total of 1,383,461 shares traded.
Over the past week, the price has changed by +3.49%, over one month by -2.22%, over three months by -4.22% and over the past year by +9.74%.
What are the forecast for CAH stock price target?
According to ValueRays Forecast Model, CAH Cardinal Health will be worth about 112.8 in July 2025. The stock is currently trading at 98.35. This means that the stock has a potential upside of +14.68%.
Issuer Forecast Upside
Wallstreet Target Price 113.6 15.5
Analysts Target Price 98.6 0.23
ValueRay Target Price 112.8 14.7